Céleste Lebbé
Has grant
FranceResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
national cohort of patients with metastatic melanoma stage IV or unresectable stage III with the objective of setting up a epidemiological monitoring and a clinico-biological database, MELBASE
Open Date: 2012-05-16
Close Date: 2015-05-15
Grant: Close
Phase II multicentric uncontrolled national trial assessing the efficacy of Nilotinib in treatment of primary melanomas , stage III unresectable melanomas, or Stage IV melanomas with c-KIT mutation or amplification.
Open Date: 2010-07-21
Close Date: 2014-01-21
Articles (6)
Although systemic treatments are warranted in aggressive forms of classic and endemic Kaposi sarcomas (KS), therapeutic guidelines are lacking for those nonimmunodeficient subtypes. In this retrospective multicentre study, we showed that paclitaxel, liposomal doxorubicin and low-dose interferon had good overall response rates for nonimmunodeficient KS with acceptable tolerance profiles. In addition, we highlighted the aggressiveness of endemic KS compared with classic KS with a higher risk of dissemination and response depletion as progression proceeded.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Collaborators (7)
caroline robert
Professeur des Universités et Praticien Hospitalier Université Paris-Saclay
Université de Paris Faculté de Santé
matthieu resche-rigon
Professor
-
Tarek Meniawy
University of Western Australia
maxime battistella
Assistant professor
Université Paris Diderot
Dirk Schadendorf
University Hospital Essen
Pippa Corrie
Cambridge University Hospitals NHS Foundation Trust
Piotr Rutkowski
Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.